Skip to main content
Andrew Brown, MD, Oncology, Livingston, NJ

AndrewBrownMD

Oncology Livingston, NJ

Gastrointestinal Cancer, Head & Neck Cancer, Neuro-Oncology, Thoracic Cancer

Attending Physician

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Brown's full profile

Already have an account?

  • Office

    94 Old Short Hills Road
    2nd Floor
    Livingston, NJ 07039
    Phone+1 973-322-5650
    Fax+1 973-322-5759

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2011 - 2025
  • NY State Medical License
    NY State Medical License 2005 - 2012
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Impact of comprehensive genomic profiling (CGP) on physician treatment recommendations in metastatic solid tumor pts who previously failed at least two standard therap...  
    Stuart P. Leitner, Andrew Bennett Brown, Miguel Conde, I. Robert Grossman, Richard Alan Michaelson, Delia Radovich, Michael Scoppetuolo, Jennifer A. Wagmiller, Norma A..., J Clin Oncol 33, 2015 (suppl; abstr e22054, 3/6/2015

Press Mentions

  • It's Not Too Late: Quitting Smoking After a Lung Cancer Diagnosis Can Help
    It's Not Too Late: Quitting Smoking After a Lung Cancer Diagnosis Can HelpJuly 26th, 2021
  • Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer
    Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021

Committees

  • Co-Director, Saint Barnabas Lung Cancer Screening Program 2012 - Present

Professional Memberships